techl8

Dassault Systèmes is in talks

Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences

Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate's push into life sciences

Source: Financial Times · Opens in new tab